title: Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia.
abstract: OBJECTIVE
  Notch signal pathway plays a fundamental role in regulating haematopoietic development. It is also an important mediator of growth and survival in several cancer types, with Notch pathway genes functioning as oncogenes or tumor suppressors in different cancers. However, the clinical role of Notch signal pathway in acute myeloid leukemia (AML) remains unclear.
  
  
  METHODS
  To address this problem, we investigated the gene expression levels of Notch signal pathway members (Notch1, Jagged1 and Delta1) in bone marrow mononuclear cells by real-time quantitative PCR in a cohort of 100 patients with newly diagnosed de novo AML and normal marrow donors. The prognostic values of the three molecules in AML were also analyzed.
  
  
  RESULTS
  Comparing with the normal controls, we show the transcriptional up-regulation of Notch1, Jagged1 and Delta1 in the bone marrow of AML patients with statistic differences (P = 0.008, 0.01 and 0.01, respectively). In addition, univariate analysis of factors associated with relapse-free survival and overall survival showed a significantly shorter survival in the patients with unfavorable karyotype, higher Notch1 expression, higher Jagged1 expression, or higher Delta1 expression. Moreover, Cox proportional hazards multivariate analysis of the univariate predictors identified karyotype and gene expression levels of Notch1, Jagged1 and Delta1 as independent prognostic factors for relapse-free survival and overall survival. Furthermore, the prognostic significance of Notch1, Jagged1 and Delta1 expression was more obvious in the subgroup of patients with intermediate-risk cytogenetics.
  
  
  CONCLUSIONS
  Taken together, our data suggest for the first time that the activation of Notch pathway may indicate a poor prognosis in AML. Especially, Notch1, Jagged1 and Delta1 expression may be relevant prognostic markers in intermediate risk AML.
authors.affiliation: The Affiliated Jiangyin Hospital of Southeast University Medical College, 214400 Jiangyin, Jiangsu, Peoples Republic of China. xux.jyh@gmail.com
authors.forename: Xin
authors.initials: X
authors.lastname: Xu
authors.forename: Yu
authors.initials: Y
authors.lastname: Zhao
authors.forename: Maozhong
authors.initials: M
authors.lastname: Xu
authors.forename: Qiuxin
authors.initials: Q
authors.lastname: Dai
authors.forename: Wenjun
authors.initials: W
authors.lastname: Meng
authors.forename: Jiangang
authors.initials: J
authors.lastname: Yang
authors.forename: Rujuan
authors.initials: R
authors.lastname: Qin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism*; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D000072100:Jagged-1 Protein; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000378:metabolism* / Q000401:mortality; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism*; D008875:Middle Aged; D011379:Prognosis; D051881:Receptor, Notch1 / Q000378:metabolism*; D000072099:Serrate-Jagged Proteins; D015398:Signal Transduction; D015996:Survival Rate
chemical_list: D014408:Biomarkers, Tumor; D002135:Calcium-Binding Proteins; D036341:Intercellular Signaling Peptides and Proteins; D047908:Intracellular Signaling Peptides and Proteins; C000606273:JAG1 protein, human; D000072100:Jagged-1 Protein; D008565:Membrane Proteins; C497761:NOTCH1 protein, human; D051881:Receptor, Notch1; D000072099:Serrate-Jagged Proteins; C064045:delta protein
references.citation: J Urol. 2008 Jul;180(1):361-6
references.pmid: 18499162
references.citation: Blood. 2002 May 1;99(9):3398-403
references.pmid: 11964309
references.citation: Cancer Treat Res. 2010;145:67-83
references.pmid: 20306246
references.citation: Oncogene. 2010 Apr 29;29(17):2488-98
references.pmid: 20154720
references.citation: Int J Lab Hematol. 2010 Apr;32(2):150-8
references.pmid: 19302234
references.citation: Immunity. 1999 Sep;11(3):299-308
references.pmid: 10514008
references.citation: Oncol Rep. 2009 Sep;22(3):631-4
references.pmid: 19639214
references.citation: Immunity. 1998 Jan;8(1):43-55
references.pmid: 9462510
references.citation: Am J Pathol. 2010 Apr;176(4):2019-28
references.pmid: 20167860
references.citation: Med Oncol. 2011 Mar;28(1):270-8
references.pmid: 20300979
references.citation: ScientificWorldJournal. 2009 Dec 16;9:1438-48
references.pmid: 20024517
references.citation: Leuk Lymphoma. 2001 Jul;42(3):467-72
references.pmid: 11699411
references.citation: Cancer Treat Res. 2009;152:479-96
references.pmid: 20213410
references.citation: Clin Cancer Res. 2008 May 15;14(10):2962-9
references.pmid: 18483362
references.citation: Cancer Res. 2004 Oct 1;64(19):6854-7
references.pmid: 15466172
references.citation: Oncol Rep. 2010 Jan;23(1):35-43
references.pmid: 19956862
references.citation: Neoplasia. 2006 Dec;8(12):1072-82
references.pmid: 17217625
references.citation: Int J Cancer. 2000 Nov 1;88(3):401-10
references.pmid: 11054669
references.citation: Cell. 1991 Aug 23;66(4):649-61
references.pmid: 1831692
references.citation: Cancer Treat Res. 2010;145:85-108
references.pmid: 20306247
references.citation: Cancer Lett. 2005 Feb 28;219(1):113-20
references.pmid: 15694671
references.citation: Oncol Rep. 2007 Dec;18(6):1395-402
references.pmid: 17982622
references.citation: J Biol Chem. 2010 May 14;285(20):15010-15015
references.pmid: 20233720
references.citation: Mol Cell Biochem. 2010 Jul;340(1-2):7-14
references.pmid: 20157766
references.citation: Stem Cells. 2010 Jan;28(1):5-16
references.pmid: 19904829
references.citation: J Oral Pathol Med. 2010 Aug 1;39(7):552-8
references.pmid: 20337864
references.citation: Leukemia. 2003 Jan;17(1):9-16
references.pmid: 12529654
references.citation: Immunity. 1999 May;10(5):547-58
references.pmid: 10367900
references.citation: Biotechniques. 2002 Jun;32(6):1372-4, 1376, 1378-9
references.pmid: 12074169
references.citation: Neoplasma. 2009;56(6):533-41
references.pmid: 19728763
references.citation: Lab Invest. 1999 Jan;79(1):67-79
references.pmid: 9952112
references.citation: J Clin Oncol. 2010 Apr 20;28(12):2101-7
references.pmid: 20308656